Additional file 10 of γ-Secretase modulator resistance of an aggressive Alzheimer-causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds

Supplementary Material 10: Figure S10. Ngn2-expressing iPSCs can be differentiated into cortical neurons after doxycycline induction. (A) Schematic workflow of the differentiation protocol (DOX, doxycycline; Puro, puromycine; 5FU, 5-fluorouracil), see Materials and methods for details. (B) Single channel and merged immunofluorescence stainings (DAPI (blue), Tau (green), MAP2 (pink) and Tuj1 (green)) of differentiated neurons at day 27. The merged picture is also shown in Fig. 5B. Magnification: 63x; Scalebar: 10 µm.

Institutions

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.28448806
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Additional file 10 of γ-Secretase modulator resistance of an aggressive Alzheimer-causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds

Figshare
Alzheimer's disease research and treatments
article

Additional file 10 of γ-Secretase modulator resistance of an aggressive Alzheimer-causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds

article en

Abstract

Supplementary Material 10: Figure S10. Ngn2-expressing iPSCs can be differentiated into cortical neurons after doxycycline induction. (A) Schematic workflow of the differentiation protocol (DOX, doxycycline; Puro, puromycine; 5FU, 5-fluorouracil), see Materials and methods for details. (B) Single channel and merged immunofluorescence stainings (DAPI (blue), Tau (green), MAP2 (pink) and Tuj1 (green)) of differentiated neurons at day 27. The merged picture is also shown in Fig. 5B. Magnification: 63x; Scalebar: 10 µm.

Figshare
Roche (Switzerland) (CH), German Center for Neurodegenerative Diseases (DE), LMU Klinikum (DE), Munich Cluster for Systems Neurology (DE), Ludwig-Maximilians-Universität München (DE)
Openalex Percentile: Top 44%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.